Neuroleptic-induced dystonia: incidence and risk factors

By Ballerini M.   Bellini S.   Niccolai C.   Pieroni V.   Ferrara M.  

European Psychiatry, Vol. 17, Iss. 6, 2002-10 ,pp. : 366-368

Elsevier

Access to resources Recommend Favorite

Increased frequency of α-synuclein in the substantia nigra in human immunodeficiency virus infection

By Khanlou Negar   Moore David   Chana Gursharan   Cherner Mariana   Lazzaretto Deborah   Dawes Sharron   Grant Igor   Masliah Eliezer   Everall Ian  

Journal of NeuroVirology, Vol. 15, Iss. 2, 2009-04 ,pp. : 131-138

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Cross-sectional study discloses a positive family history for Parkinson's disease and male gender as epidemiological risk factors for substantia nigra hyperechogenicity

By Schweitzer K. J.   Behnke S.   Liepelt I.   Wolf B.   Grosser C.   Godau J.   Gaenslen A.   Bruessel T.   Wendt A.   Abel F.   Müller A.   Gasser T.   Berg D.  

Journal of Neural Transmission, Vol. 114, Iss. 9, 2007-09 ,pp. : 1167-1171

Springer Publishing Company

Access to resources Recommend Favorite

Regional and age specific effects of zolpidem microinfusions in the substantia nigra on seizures

By Velskova J.   Loscher W.   Moshe S.L.  

Epilepsy Research, Vol. 30, Iss. 2, 1998-04 ,pp. : 107-114

Elsevier

Access to resources Recommend Favorite

MPP⁺Induced Substantia Nigra Degeneration Is Attenuated in nNOS Knockout Mice

By Matthews R.T.   Beal M.F.   Fallon J.   Fedorchak K.   Huang P.L.   Fishman M.C.   Hyman B.T.  

Neurobiology of Disease, Vol. 4, Iss. 2, 1997-02 ,pp. : 114-121

Academic Press

Access to resources Recommend Favorite